Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Gliosarcoma 11Glioblastoma 11Prostatic Neoplasms 7Lung Neoplasms 6Head and Neck Neoplasms 6Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Pancreatic Neoplasms 5Brain Neoplasms 4Astrocytoma 4Adenocarcinoma of Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Pinealoma 2Oligodendroglioma 2Meningioma 2Medulloblastoma 2Malignant mesenchymal tumor 2Liver Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Glioma 2Fibrosarcoma 2Ependymoma 2

Interventions

Radiotherapy 5Temozolomide 4Radiation 3Irinotecan 3Bevacizumab 3ribociclib 2abemaciclib 2Vorinostat 2Mebendazole 2Everolimus 2Dasatinib 2vandetanib 1temsirolimus 1sargramostim 1reolysin 1pembrolizumab 1ovex 1nimotuzumab 1irinotecan sucrosofate 1dinutuximab 1crenolanib 1adavosertib 1Vincristine 1Valproic Acid 1Sirolimus 1Re-Irradiation 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation Dose Hypofractionation 1Piperazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diffuse Intrinsic Pontine Glioma × Radiotherapy, Conformal × Clear all
NCT01189266 2021-10-28

Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

National Cancer Institute (NCI)

Phase 1/2 Completed
79 enrolled 17 charts
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡